May 19, 2015
Wellesley, Mass., May 19, 2015 –BCC Research reveals in its new report on nebulizers, inhalers and respirators that a number of factors are increasing both costs and sales of asthmatic treatment equipment. Market drivers include a rise in the number of asthma cases, an expanding elder population, increased rates of smoking and obesity, more pollution and heavy patenting of branded products (in the U.S., especially).
The asthmatic treatment device market is forecast to grow at a compound annual growth rate (CAGR) of 8.9% between 2013 and 2019. In 2019, global market value should reach $19 billion. Asia is forecast as the largest growth area, with a five-year CAGR of 11.8%. Worldwide, the nebulizer, inhaler, and respirator markets are predicted to grow at CAGRs of 9.2%, 7.3% and 10.4%, respectively.
All global regions are expected to experience a 50% increase over the next decade in asthmatic disease cases. Children in countries with high pollution levels, such as China and India, are becoming increasingly susceptible to asthma and the disease remains one of the largest reasons for children’s hospital visits.
The rapid increase in the number of new asthma cases globally, along with technological developments achieved through exploration of new surgical procedures, are fueling healthy market growth. Also, generic drugs and equipment will play an increasing role in the industry as U.S. patent expiry dates mature.
“Continued studies on asthmatic conditions remain prevalent at universities and companies, providing R&D for the continued assessment of the needs of asthmatic patients through continuous research into respiratory diseases,” says BCC Research analyst Smruti Munshi. “Pricing, product development and product launch times continue to remain competitive factors that determine the growth of the asthmatic treatment device market.”
Nebulizers, Inhalers and Respirators for Asthma Treatment: Global Markets (HLC177A) provides insights on the causes of asthma, as well as information about equipment used in the treatment of asthma. By examining the disease, examining trends, analyzing equipment and processes, the report forecasts trends and sales of asthma devices through 2019.
Editors and reporters who wish to speak with the analyst should contact Steven Cumming at email@example.com.
Nebulizers, Inhalers and Respirators for Asthma Treatment: Global Markets( HLC177A )
Publish Date: Mar 2015
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email firstname.lastname@example.org or visit www.bccresearch.com/media to request access to our library of market research.